Page last updated: 2024-10-28

gyki 52466 and Angiospasm, Intracranial

gyki 52466 has been researched along with Angiospasm, Intracranial in 1 studies

GYKI 52466: an AMPA (non-NMDA) receptor antagonist; structure given in first source

Research Excerpts

ExcerptRelevanceReference
"The pathogenesis and treatment of cerebral vasospasm (CV) after subarachnoid hemorrhage (SAH) remains a matter of discussion."1.35Effects of GYKI 52466 on early vasospasm in rats. ( Akdemir, O; Colak, A; Karaoglan, A; Kokturk, S; Sagmanligil, A; Soy, O; Tasyurekli, M, 2009)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Colak, A1
Soy, O1
Karaoglan, A1
Akdemir, O1
Kokturk, S1
Sagmanligil, A1
Tasyurekli, M1

Other Studies

1 other study available for gyki 52466 and Angiospasm, Intracranial

ArticleYear
Effects of GYKI 52466 on early vasospasm in rats.
    Central European neurosurgery, 2009, Volume: 70, Issue:4

    Topics: Animals; Benzodiazepines; Excitatory Amino Acid Antagonists; Femoral Artery; Microscopy, Electron, T

2009